Quick Answer
Sigyn Therapeutics, Inc. reported Shares Outstanding of 1.61 million shares for fiscal year 2024.
Sigyn Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2024 | 1.61M | +24.6% |
| 2023 | 1.29M | -97.0% |
| 2023 | 42.71M | +4365.1% |
| 2022 | 956,595 | -97.4% |
| 2021 | 37.30M | +5.9% |
| 2020 | 35.20M | +6940.3% |
| 2019 | 500,000 | -99.4% |
| 2018 | 81.27M | +52.5% |
| 2017 | 53.28M | +55.2% |
| 2015 | 34.32M | +114.5% |
| 2014 | 16.00M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 1.61M | +13.0% | +0.0% |
| June 30, 2025 | 1.61M | +27.0% | +0.0% |
| March 31, 2025 | 1.61M | +31.1% | +0.0% |
| December 31, 2024 | 1.61M | +24.6% | +13.0% |
| September 30, 2024 | 1.42M | -96.8% | +12.4% |
| June 30, 2024 | 1.26M | -97.1% | +3.2% |
| March 31, 2024 | 1.22M | -97.1% | -4.9% |
| December 31, 2023 | 1.29M | -96.6% | -97.1% |
- Sigyn Therapeutics, Inc. showed an increase of +24.6% in Shares Outstanding compared to the prior fiscal year.
- Over the 2014–2024 period, Sigyn Therapeutics, Inc.’s shares outstanding has declined by 90.0% (from 16.00 million shares to 1.61 million shares).
- The most recent figure is from Sigyn Therapeutics, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: